Kura Oncology Inc
KURAHealthcare|Biotechnology|USA
$11.44
-0.63 (-5.22%)
Tangible Book
$1.22
Earnings Power
$4.33
About
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
Stock Price
+79.9%(1Y)
Pipeline Summary
23 total trials14
Phase 1
9
Phase 2
1
Phase 3
0
Phase 4
Completed: 5Terminated: 3NOT_YET_RECRUITING: 2Recruiting: 9Withdrawn: 1AVAILABLE: 2Active: 1
Active Trials (10)
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
NCT06026410Solid Tumors With HRAS Alterations
Phase 1Recruiting
Enrollment: 300 participants
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
NCT06001788AML
Phase 1Recruiting
Enrollment: 171 participants
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
NCT05735184Acute Myeloid Leukemia
Phase 1Recruiting
Enrollment: 420 participants
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
NCT07007312Acute Myeloid Leukemia (AML)
Phase 3Recruiting
Enrollment: 1,300 participants
A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias
NCT06397027Refractory Acute Leukemia
Phase 1Recruiting
Enrollment: 22 participants
BioScore
5.4/10
Watchlist
Ownership
Recent Insider Trades
Leoni MollieSELL
2026-06-1884,929 shares @ $9.82
Powl Brian T.SELL
2026-05-2110,000 shares @ $11
Powl Brian T.SELL
2026-05-19339 shares @ $9.21
FORD KATHLEENSELL
2026-05-192,257 shares @ $9.08
Bair Teresa BrophySELL
2026-05-182,256 shares @ $9.38
Recent News
2026-06-15 14:33:16
Data last updated: Jul 12, 2026, 07:38 PM